跳至主要内容
临床试验/NCT02232984
NCT02232984已完成不适用

Quadripolar CRT-D On Currently Approved Lead SystemS

Boston Scientific Corporation60 个研究点 分布在 1 个国家目标入组 749 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
749
试验地点
60
主要终点
Number of Vectors With Phrenic Nerve Stimulation (PNS)

研究概览

简要总结

The purpose of the study is to evaluate different ways to program around extracardiac stimulation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is medically indicated for implantation with a Boston Scientific (BSC) DYNAGEN or INOGEN X4 CRT-D (or any future FDA approved BSC X4 CRT-D) and already implanted with/scheduled to receive a commercially available quadripolar left ventricular lead
  • Subject is willing and capable of providing informed consent and participating in all testing and study visits associated with this investigation at an approved center and at the intervals defined by this protocol
  • Subject is age 18 or above, or of legal age to give informed consent specific to state and national law

排除标准

  • Subject has a known or suspected sensitivity to dexamethasone acetate (DXA)
  • Subject is enrolled in any other concurrent study, without prior approval from BSC
  • Women of childbearing potential who are or might be pregnant at the time of study enrollment

结局指标

主要结局

Number of Vectors With Phrenic Nerve Stimulation (PNS)

时间窗: Pre-discharge (up to 7 days post implant)

The primary objective of this study was to characterize the performance of Boston Scientific (BSC) unique pacing vectors vs. BSC/St Jude Medical (STJ) common pacing vectors to prevent phrenic nerve stimulation (PNS) based on the selected pacing cathode. BSC unique vectors are those that are only available with Boston Scientific's (BSC) quadripolar (X4) CRT-Ds while common vectors are those that are available for both BSC and STJ systems.

次要结局

  • Final LV Lead Impedance at Pre-discharge(Pre-discharge (up to 7 days post implant))
  • Final Pacing Treshold at Pre-discharge(Pre-discharge (up to 7 days post implant))
  • Final Sensing Amplitude at Pre-discharge(Pre-discharge (up to 7 days post implant))
  • Delivery System Comparison Between ACUITY Pro and the Other Delivery Systems(At time of implantation (0 to 30 days post consent signature))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (60)

Loading locations...

相似试验